Peter Sever
Impact in
-
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Cardiovascular Health and Disease Prevention
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hormonal Regulation and Hypertension
Papers in
-
- Blood Pressure and Hypertension Studies 70
- Heart Rate Variability and Autonomic Control 16
- Renin-Angiotensin System Studies 11
-
- Hormonal Regulation and Hypertension 23
- Co-authors
- Neil R Poulter (58 shared papers)Eoin T O'Brien (15 shared papers)Gordon T. McInnes (16 shared papers)Hans Wedel (25 shared papers)Marc Steven Sabatine (19 shared papers)Mark J. Caulfield (20 shared papers)ANTHONY C. KEECH (17 shared papers)Robert Patrick Giugliano (18 shared papers)
- Journals
- Journal of Hypertension (22 papers)The Lancet (18 papers)Journal of the Renin-Angiotensin-Aldosterone System (15 papers)Hypertension (13 papers)European Heart Journal (11 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Peter Sever
237 papers receiving 34.3k citations
Peter Sever's Hit Papers
Peers
Comparison fields: 5 of 193
- Cardiology and Cardiovascular Medicine 11.4k
- Endocrinology, Diabetes and Metabolism 6.6k
- Surgery 11.6k
- Genetics 5.1k
- Family Practice 227
Countries citing papers authored by Peter Sever
This map shows the geographic impact of Peter Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sever more than expected).
Fields of papers citing papers by Peter Sever
This network shows the impact of papers produced by Peter Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sever. The network helps show where Peter Sever may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 244 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease Hit paper breakdown → | 2017 | 4576 |
| 2 | Genetic studies of body mass index yield new insights for obesity biology Hit paper breakdown → | 2015 | 3477 |
| 3 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Hit paper breakdown → | 2003 | 3011 |
| 4 | Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Hit paper breakdown → | 2005 | 2180 |
| 5 | Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Hit paper breakdown → | 2010 | 1451 |
| 6 | Interpretation of the evidence for the efficacy and safety of statin therapy Hit paper breakdown → | 2016 | 1442 |
| 7 | Defining the role of common variation in the genomic and biological architecture of adult human height Hit paper breakdown → | 2014 | 1377 |
| 8 | Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial Hit paper breakdown → | 2015 | 937 |
| 9 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 727 |
| 10 | British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary Hit paper breakdown → | 2004 | 644 |
| 11 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Hit paper breakdown → | 2017 | 612 |
| 12 | Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials Hit paper breakdown → | 2019 | 604 |
| 13 | Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke Hit paper breakdown → | 2010 | 556 |
| 14 | Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials Hit paper breakdown → | 2015 | 537 |
| 15 | Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension Hit paper breakdown → | 2007 | 493 |
| 16 | The trans-ancestral genomic architecture of glycemic traits Hit paper breakdown → | 2021 | 490 |
| 17 | Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA) Hit paper breakdown → | 2004 | 476 |
| 18 | A saturated map of common genetic variants associated with human height Hit paper breakdown → | 2022 | 456 |
| 19 | Exome-wide association study of plasma lipids in >300,000 individuals Hit paper breakdown → | 2017 | 437 |
| 20 | Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk Hit paper breakdown → | 2017 | 429 |
About Peter Sever
Peter Sever is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Genetics and Physiology, having authored 244 papers that have together received 36.4k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (70 papers), Lipoproteins and Cardiovascular Health (40 papers), Genetic Associations and Epidemiology (30 papers), Hormonal Regulation and Hypertension (23 papers), Heart Rate Variability and Autonomic Control (16 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Renin-Angiotensin System Studies (11 papers) and Sodium Intake and Health (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (11.4k citations), Endocrinology, Diabetes and Metabolism (6.6k citations), Surgery (11.6k citations), Genetics (5.1k citations) and Family Practice (227 citations). Peter Sever has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Neil R Poulter, Eoin T O'Brien, Gordon T. McInnes, Hans Wedel, Marc Steven Sabatine, Mark J. Caulfield, ANTHONY C. KEECH, Robert Patrick Giugliano, Terje Rolf Pedersen and Sverre Erik Kjeldsen. Their work appears in journals such as Journal of Hypertension, The Lancet, Journal of the Renin-Angiotensin-Aldosterone System, Hypertension and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.